Osteoarthritis: Cellular and molecular changes in degenerating cartilage

Progress in Histochemistry and Cytochemistry

Volumn 40, Issue 3, 2006, Pages 135-163

  Lorenz, Helga ^a   Richter, Wiltrud ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Animal model; Cartilage degeneration; Collagen; Extracellular matrix; Gene expression; Histology; Osteoarthritis; Proteoglycan

Indexed keywords

AGGRECAN; AGGRECANASE; BIGLYCAN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 6; COLLAGENASE 3; DECORIN; DNA; FIBROMODULIN; FIBRONECTIN; GELATINASE B; GLYCOSAMINOGLYCAN; HEXOSAMINE; INTERSTITIAL COLLAGENASE; LUMICAN; PROTEOGLYCAN; RNA; STROMELYSIN; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; URONIC ACID;

ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CELL METABOLISM; CHEMICAL ANALYSIS; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CYTOCHEMISTRY; CYTOPATHOLOGY; DISEASE COURSE; DISEASE SEVERITY; DNA CONTENT; DOG; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; GENE EXPRESSION PROFILING; HISTOCHEMISTRY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOLECULAR BIOLOGY; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PROTEOGLYCAN SYNTHESIS; RABBIT; RNA ANALYSIS; WATER CONTENT;

ANIMALIA;

EID: 33744798189     PISSN: 00796336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.proghi.2006.02.003     Document Type: Article

References (122)

1. Adams M.E. Cartilage hypertrophy following canine anterior cruciate ligament transection differs among different areas of the joint. J Rheumatol 16 6 (1989) 818-824
2. Adams M.E., and Brandt K.D. Hypertrophic repair of canine articular cartilage in osteoarthritis after anterior cruciate ligament transection. J Rheumatol 18 3 (1991) 428-435
3. Adams M.E., Matyas J.R., Huang D., and Dourado G.S. Expression of proteoglycans and collagen in the hypertrophic phase of experimental osteoarthritis. J Rheumatol Suppl 43 (1995) 94-97
4. Aigner T., and McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci 59 1 (2002) 5-18
5. Aigner T., Stoss H., Weseloh G., Zeiler G., and von der Mark K. Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B. Cell Pathol. Incl Mol. Pathol. 62 6 (1992) 337-345
6. Aigner T., Reichenberger E., Bertling W., Kirsch T., Stoss H., and von der Mark K. Type X collagen expression in osteoarthritic and rheumatoid articular cartilage. Virchows Arch B. Cell Pathol.Incl Mol Pathol. 63 4 (1993) 205-211
7. Aigner T., Vornehm S.I., Zeiler G., Dudhia J., von der Mark K., and Bayliss M.T. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum 40 3 (1997) 562-569
8. Aigner T., Zien A., Gehrsitz A., Gebhard P.M., and McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44 12 (2001) 2777-2789
9. Appleyard R.C., Burkhardt D., Ghosh P., Read R., Cake M., Swain M.V., et al. Topographical analysis of the structural, biochemical and dynamic biomechanical properties of cartilage in an ovine model of osteoarthritis. Osteoarthritis Cartilage 11 1 (2003) 65-77
10. Bau B., Haag J., Schmid E., Kaiser M., Gebhard P.M., and Aigner T. Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or down-regulated in osteoarthritic cartilage. J Bone Miner Res 17 12 (2002) 2141-2150
11. Bluteau G., Conrozier T., Mathieu P., Vignon E., Herbage D., and Mallein-Gerin F. Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526 2 (2001) 147-158
12. Bluteau G., Gouttenoire J., Conrozier T., Mathieu P., Vignon E., Richard M., et al. Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section. Biorheology 39 1-2 (2002) 247-258
13. Bock H.C., Michaeli P., Bode C., Schultz W., Kresse H., Herken R., et al. The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis. Osteoarthritis Cartilage 9 7 (2001) 654-663
14. Boos N., Nerlich A.G., Wiest I., von der Mark K., Ganz R., and Aebi M. Immunohistochemical analysis of type-X-collagen expression in osteoarthritis of the hip joint. J Orthop Res 17 4 (1999) 495-502
15. Brandt K.D., Braunstein E.M., Visco D.M., O'Connor B., Heck D., and Albrecht M. Anterior (cranial) cruciate ligament transection in the dog: a bona fide model of osteoarthritis, not merely of cartilage injury and repair. J Rheumatol 18 3 (1991) 436-446
16. Brandt K.D., Myers S.L., Burr D., and Albrecht M. Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum 34 12 (1991) 1560-1570
17. Braunstein E.M., Brandt K.D., and Albrecht M. MRI demonstration of hypertrophic articular cartilage repair in osteoarthritis. Skeletal Radiol 19 5 (1990) 335-339
18. Carney S.L., Billingham M.E., Muir H., and Sandy J.D. Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritis. J Orthop Res 2 3 (1984) 201-206
19. Carney S.L., Billingham M.E., Caterson B., Ratcliffe A., Bayliss M.T., Hardingham T.E., et al. Changes in proteoglycan turnover in experimental canine osteoarthritic cartilage. Matrix 12 2 (1992) 137-147
20. Chevalier X., Groult N., Larget-Piet B., Zardi L., and Hornebeck W. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 37 7 (1994) 1013-1022
21. Chiquet-Ehrismann R., and Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 200 4 (2003) 488-499
22. Chubinskaya S., Kuettner K.E., and Cole A.A. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest 79 12 (1999) 1669-1677
23. Connor J.R., Dodds R.A., Emery J.G., Kirkpatrick R.B., Rosenberg M., and Gowen M. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. Osteoarthritis Cartilage 8 (2000) 87-95
24. Cs-Szabo G., Melching L.I., Roughley P.J., and Glant T.T. Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum 40 6 (1997) 1037-1045
25. de Rooster H., Cox E., and van Bree H. Prevalence and relevance of antibodies to type-I and -II collagen in synovial fluid of dogs with cranial cruciate ligament damage. Am J Vet Res 61 11 (2000) 1456-1461
26. Dourado G S., Adams M.E., Matyas J.R., and Huang D. Expression of biglycan, decorin and fibromodulin in the hypertrophic phase of experimental osteoarthritis. Osteoarthritis Cartilage 4 3 (1996) 187-196
27. Dumond H., Presle N., Pottie P., Pacquelet S., Terlain B., Netter P., et al. Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis. Osteoarthritis Cartilage 12 4 (2004) 284-295
28. Ehrlich M.G., Mankin H.J., Jones H., Wright R., Crispen C., and Vigliani G. Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage. J Clin Invest 59 2 (1977) 226-233
29. Eyre D.R., McDevitt C.A., Billingham M.E., and Muir H. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 188 3 (1980) 823-837
30. Fehr J.E., Trotter G.W., Oxford J.T., and Hart D.A. Comparison of Northern blot hybridization and a reverse transcriptase-polymerase chain reaction technique for measurement of mRNA expression of metalloproteinases and matrix components in articular cartilage and synovial membrane from horses with osteoarthritis. Am J Vet Res 61 8 (2000) 900-905
31. Felson D.T. Osteoarthritis. Rheum Dis Clin North Am 16 3 (1990) 499-512
32. Fernandes J.C., Martel-Pelletier J., Lascau-Coman V., Moldovan F., Jovanovic D., Raynauld J.P., et al. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol 25 8 (1998) 1585-1594
33. Flannelly J., Chambers M.G., Dudhia J., Hembry R.M., Murphy G., Mason R.M., et al. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthritis Cartilage 10 9 (2002) 722-733
34. Floman Y., Eyre D.R., and Glimcher M.J. Induction of osteoarthrosis in the rabbit knee joint: biochemical studies on the articular cartilage. Clin Orthop 147 (1980) 278-286
35. Gaffen J.D., Bayliss M.T., and Mason R.M. Elevated aggrecan mRNA in early murine osteoarthritis. Osteoarthritis Cartilage 5 4 (1997) 227-233
36. Garnero P., Piperno M., Gineyts E., Christgau S., Delmas P.D., and Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60 6 (2001) 619-626
37. Garnero P., Conrozier T., Christgau S., Mathieu P., Delmas P.D., and Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 62 10 (2003) 939-943
38. Glasson S.S., Askew R., Sheppard B., Carito B.A., Blanchet T., Ma H.L., et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 50 8 (2004) 2547-2558
39. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434 7033 (2005) 644-648
40. Goldwasser M., Astley T., van der Rest M., and Glorieux F.H. Analysis of the type of collagen present in osteoarthritic human cartilage. Clin Orthop 167 (1982) 296-302
41. Grynpas M.D., Gahunia H.K., Yuan J., Pritzker K.P., Hartmann D., and Tupy J.H. Analysis of collagens solubilized from cartilage of normal and spontaneously osteoarthritic rhesus monkeys. Osteoarthritis Cartilage 2 4 (1994) 227-234
42. Hakala B.E., White C., and Recklies A.D. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268 (1993) 25803-25810
43. Hambach L., Neureiter D., Zeiler G., Kirchner T., and Aigner T. Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum 41 6 (1998) 986-996
44. Hayami T., Funaki H., Yaoeda K., Mitui K., Yamagiwa H., Tokunaga K., et al. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol 30 10 (2003) 2207-2217
45. Hegemann N., Kohn B., Brunnberg L., and Schmidt M.F. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage 10 9 (2002) 714-721
46. Hering T.M. Molecular biology of cartilage repair. In: Kuettner K., and Goldberg V. (Eds). Osteoarthritic Disorders (1995), American Association of Orthopaedic surgeons, Rosemond, Illinois 329-340
47. Homandberg G.A., Meyers R., and Xie D.L. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 267 6 (1992) 3597-3604
48. Hu B., Trinh K., Figueira W.F., and Price P.A. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 271 (1996) 19415-19420
49. Huebner J.L., Otterness I.G., Freund E.M., Caterson B., and Kraus V.B. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum 41 5 (1998) 877-890
50. Jennings L., Wu L., King K.B., Hammerle H., Cs-Szabo G., and Mollenhauer J. The effects of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes. Connect Tissue Res 42 1 (2001) 71-86
51. Jung M., Christgau S., Lukoschek M., Henriksen D., and Richter W. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology 71 2 (2004) 70-76
52. Kashiwagi M., Tortorella M., Nagase H., and Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 276 16 (2001) 12501-12504
53. Knorr T., Obermayr F., Bartnik E., Zien A., and Aigner T. YKL-39 (chitinase 3-like protein 2), but not YKL-40 (chitinase 3-like protein 1), is up regulated in osteoarthritic chondrocytes. Ann Rheum Dis 62 10 (2003) 995-998
54. Kumar S., Connor J.R., Dodds R.A., Halsey W., Van Horn M., Mao J., et al. Identification and initial characterization of 5000 expressed sequenced tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA libraries. Osteoarthritis Cartilage 9 7 (2001) 641-653
55. Le Graverand M.P., Eggerer J., Vignon E., Otterness I.G., Barclay L., and Hart D.A. Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis. J Orthop Res 20 3 (2002) 535-544
56. Lippiello L., Hall D., and Mankin H.J. Collagen synthesis in normal and osteoarthritic human cartilage. J Clin Invest 59 4 (1977) 593-600
57. Little C.B., Ghosh P., and Bellenger C.R. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep. J Orthop Res 14 3 (1996) 433-444
58. Liu H., McKenna L.A., and Dean M.F. An N-terminal peptide from link protein can stimulate biosynthesis of collagen by human articular cartilage. Arch Biochem Biophys 378 1 (2000) 116-122
59. Liu W., Burton-Wurster N., Glant T.T., Tashman S., Sumner D.R., Kamath R.V., et al. Spontaneous and experimental osteoarthritis in dog: similarities and differences in proteoglycan levels. J Orthop Res 21 4 (2003) 730-737
60. Lorenz H., Wenz W., Ivancic M., Steck E., and Richter W. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther 7 1 (2005) R156-R165
61. Lorenzo P., Bayliss M.T., and Heinegard D. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Matrix Biol 23 6 (2004) 381-391
62. Mankin H.J., Dorfman H., Lippiello L., and Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53 3 (1971) 523-537
63. Marijnissen A.C., van Roermund P.M., TeKoppele J.M., Bijlsma J.W., and Lafeber F.P. The canine 'groove' model, compared with the ACLT model of osteoarthritis. Osteoarthritis Cartilage 10 2 (2002) 145-155
64. Marijnissen A.C., van Roermund P.M., Verzijl N., TeKoppele J.M., Bijlsma J.W., and Lafeber F.P. Steady progression of osteoarthritic features in the canine groove model. Osteoarthritis Cartilage 10 4 (2002) 282-289
65. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 6 6 (1998) 374-376
66. Martin I., Jakob M., Schafer D., Dick W., Spagnoli G., and Heberer M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9 2 (2001) 112-118
67. Martinek V. Anatomy and pathophysiology of articular cartilage. Dtsch Z Sportmed 54 (2003) 166-170
68. Matyas J.R., Adams M.E., Huang D., and Sandell L.J. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis. Arthritis Rheum 38 3 (1995) 420-425
69. Matyas J.R., Ehlers P.F., Huang D., and Adams M.E. The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals. Arthritis Rheum 42 5 (1999) 993-1002
70. Matyas J.R., Huang D., and Adams M.E. A comparison of various "housekeeping" probes for northern analysis of normal and osteoarthritic articular cartilage RNA. Connect Tissue Res 40 3 (1999) 163-172
71. Matyas J.R., Huang D., Chung M., and Adams M.E. Regional quantification of cartilage type II collagen and aggrecan messenger RNA in joints with early experimental osteoarthritis. Arthritis Rheum 46 6 (2002) 1536-1543
72. Matyas J.R., Atley L., Ionescu M., Eyre D.R., and Poole A.R. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 50 2 (2004) 543-552
73. McDevitt C., Gilbertson E., and Muir H. An experimental model of osteoarthritis; early morphological and biochemical changes. J Bone Joint Surg Br 59 1 (1977) 24-35
74. McKenna L.A., Liu H., Sansom P.A., and Dean M.F. An N-terminal peptide from link protein stimulates proteoglycan biosynthesis in human articular cartilage in vitro. Arthritis Rheum 41 1 (1998) 157-162
75. Miosge N., Waletzko K., Bode C., Quondamatteo F., Schultz W., and Herken R. Light and electron microscopic in-situ hybridization of collagen type I and type II mRNA in the fibrocartilaginous tissue of late-stage osteoarthritis. Osteoarthritis Cartilage 6 4 (1998) 278-285
76. Miosge N., Hartmann M., Maelicke C., and Herken R. Expression of collagen type I and type II in consecutive stages of human osteoarthritis. Histochem Cell Biol 122 3 (2004) 229-236
77. Murphy-Ullrich J.E., Pallero M.A., Boerth N., Greenwood J.A., Lincoln T.M., and Cornwell T.L. Cyclic GMP-dependent protein kinase is required for thrombospondin and tenascin mediated focal adhesion disassembly. J Cell Sci 109 Pt 10 (1996) 2499-2508
78. Nagase H., and Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 5 2 (2003) 94-103
79. Nerlich A.G., Wiest I., and von der Mark K. Immunohistochemical analysis of interstitial collagens in cartilage of different stages of osteoarthrosis. Virchows Arch B. Cell Pathol Incl Mol Pathol. 63 4 (1993) 249-255
80. Niebauer G.W., Wolf B., Bashey R.I., and Newton C.D. Antibodies to canine collagen types I and II in dogs with spontaneous cruciate ligament rupture and osteoarthritis. Arthritis Rheum 30 3 (1987) 319-327
81. Okimura A., Okada Y., Makihira S., Pan H., Yu L., Tanne K., et al. Enhancement of cartilage matrix protein synthesis in arthritic cartilage. Arthritis Rheum 40 6 (1997) 1029-1036
82. Otterness I.G., Weiner E., Swindell A.C., Zimmerer R.O., Ionescu M., and Poole A.R. An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-points. Osteoarthritis Cartilage 9 3 (2001) 224-231
83. Pastoureau P.C., Chomel A.C., and Bonnet J. Evidence of early subchondral bone changes in the meniscectomized guinea pig. A densitometric study using dual-energy X-ray absorptiometry subregional analysis. Osteoarthritis Cartilage 7 5 (1999) 466-473
84. Pelletier J.P., Martel-Pelletier J., Ghandur-Mnaymneh L., Howell D.S., and Woessner Jr. J.F. Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 28 5 (1985) 554-561
85. Pelletier J.P., Mineau F., Faure M.P., and Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 33 10 (1990) 1466-1476
86. Pelletier J.P., Martel-Pelletier J., Mehraban F., and Malemud C.J. Immunological analysis of proteoglycan structural changes in the early stage of experimental osteoarthritic canine cartilage lesions. J Orthop Res 10 4 (1992) 511-523
87. Pfander D., Rahmanzadeh R., and Scheller E.E. Presence and distribution of collagen II, collagen I, fibronectin, and tenascin in rabbit normal and osteoarthritic cartilage. J Rheumatol 26 2 (1999) 386-394
88. Pfander D., Heinz N., Rothe P., Carl H.D., and Swoboda B. Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1beta: a possible explanation for the changes in matrix synthesis during osteoarthritis. Ann Rheum Dis 63 3 (2004) 240-244
89. Pond M.J., and Nuki G. Experimentally induced osteoarthritis in the dog. Ann Rheum Dis 32 4 (1973) 387-388
90. Pullig O., Weseloh G., and Swoboda B. Expression of type VI collagen in normal and osteoarthritic human cartilage. Osteoarthritis Cartilage 7 2 (1999) 191-202
91. Pullig O., Weseloh G., Gauer S., and Swoboda B. Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol 19 3 (2000) 245-255
92. Pullig O., Weseloh G., Klatt A.R., Wagener R., and Swoboda B. Matrilin-3 in human articular cartilage: increased expression in osteoarthritis. Osteoarthritis Cartilage 10 4 (2002) 253-263
93. Ratcliffe A., Billingham M.E., Saed-Nejad F., Muir H., and Hardingham T.E. Increased release of matrix components from articular cartilage in experimental canine osteoarthritis. J Orthop Res 10 3 (1992) 350-358
94. Rizkalla G., Reiner A., Bogoch E., and Poole A.R. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 90 6 (1992) 2268-2277
95. Sah R.L., Yang A.S., Chen A.C., Hant J.J., Halili R.B., Yoshioka M., et al. Physical properties of rabbit articular cartilage after transection of the anterior cruciate ligament. J Orthop Res 15 2 (1997) 197-203
96. Sakakibara Y., Miura T., Iwata H., Kikuchi T., Yamaguchi T., Yoshimi T., et al. Effect of high-molecular-weight sodium hyaluronate on immobilized rabbit knee. Clin Orthop 299 (1994) 282-292
97. Salminen H., Perala M., Lorenzo P., Saxne T., Heinegard D., Saamanen A.M., et al. Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthritis Rheum 43 8 (2000) 1742-1748
98. Salminen H.J., Saamanen A.M., Vankemmelbeke M.N., Auho P.K., Perala M.P., and Vuorio E.I. Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model. Ann Rheum Dis 61 7 (2002) 591-597
99. Salter D.M. Tenascin is increased in cartilage and synovium from arthritic knees. Br J Rheumatol 32 9 (1993) 780-786
100. Sandell L.J., and Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 3 2 (2001) 107-113
101. Sandy J.D., Adams M.E., Billingham M.E., Plaas A., and Muir H. In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum 27 4 (1984) 388-397
102. Shibakawa A., Aoki H., Masuko-Hongo K., Kato T., Tanaka M., Nishioka K., et al. Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. Osteoarthritis Cartilage 11 2 (2003) 133-140
103. Shlopov B.V., Lie W.R., Mainardi C.L., Cole A.A., Chubinskaya S., and Hasty K.A. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 40 11 (1997) 2065-2074
104. Squires G.R., Okouneff S., Ionescu M., and Poole A.R. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 48 5 (2003) 1261-1270
105. Steck E., Breit S., Breusch S.J., Axt M., and Richter W. Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage. Biochem Biophys Res Commun 299 1 (2002) 109-115
106. Stoop R., Buma P., van der Kraan P.M., Hollander A.P., Clark Billinghurst R., Robin Poole A., et al. Differences in type II collagen degradation between peripheral and central cartilage of rat stifle joints after cranial cruciate ligament transection. Arthritis Rheum 43 9 (2000) 2121-2131
107. Stove J., Gerlach C., Huch K., Gunther K.P., Brenner R., Puhl W., et al. Gene expression of stromelysin and aggrecan in osteoarthritic cartilage. Pathobiology 69 6 (2001) 333-338
108. Swoboda B. [Epidemiological arthrosis research]. Orthopade 30 11 (2001) 834-840
109. Tchetina E.V., Squires G., and Poole A.R. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 32 5 (2005) 876-886
110. Teshima R., Ono M., Yamashita Y., Hirakawa H., Nawata K., and Morio Y. Immunohistochemical collagen analysis of the most superficial layer in adult articular cartilage. J Orthop Sci 9 3 (2004) 270-273
111. Veje K., Hyllested-Winge J.L., and Ostergaard K. Topographic and zonal distribution of tenascin in human articular cartilage from femoral heads: normal versus mild and severe osteoarthritis. Osteoarthritis Cartilage 11 3 (2003) 217-227
112. Vignon E., Bejui J., Mathieu P., Hartmann J.D., Ville G., Evreux J.C., et al. Histological cartilage changes in a rabbit model of osteoarthritis. J Rheumatol 14 Spec No (1987) 104-106
113. Volck B., Ostergaard K., Johansen J.S., Garbarsch C., and Price P.A. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage. Scand J Rheumatol 28 (1999) 171-179
114. von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Gluckert K., et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 35 7 (1992) 806-811
115. Wagner S., Hofstetter W., Chiquet M., Mainil-Varlet P., Stauffer E., Ganz R., et al. Early osteoarthritic changes of human femoral head cartilage subsequent to femoro-acetabular impingement. Osteoarthritis Cartilage 11 7 (2003) 508-518
116. Wenz W., Breusch S.J., Graf J., and Stratmann U. Ultrastructural findings after intraarticular application of hyaluronan in a canine model of arthropathy. J Orthop Res 18 4 (2000) 604-612
117. Wollheim F.A. Serum markers of articular cartilage damage and repair. Rheum Dis Clin North Am 25 2 (1999) 417-432 viii
118. Wotton S.F., and Duance V.C. Type III collagen in normal human articular cartilage. Histochem J 26 5 (1994) 412-416
119. Wu W., Billinghurst R.C., Pidoux I., Antoniou J., Zukor D., Tanzer M., et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 46 8 (2002) 2087-2094
120. Yagi R., McBurney D., Laverty D., Weiner S., and Horton Jr. W.E. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 23 5 (2005) 1128-1138
121. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59 6 (2000) 455-461
122. Young A.A., Smith M.M., Smith S.M., Cake M.A., Ghosh P., Read R.A., et al. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther 7 4 (2005) R852-R861